Global Clinical Pharmacology, McNeil AB, Box 941, SE-251 09, Helsingborg, Sweden.
Quantitative Sciences, McNeil AB, Helsingborg, Sweden.
BMC Pharmacol Toxicol. 2019 Nov 21;20(1):69. doi: 10.1186/s40360-019-0368-9.
Ability to manage urges to smoke is fundamental to maximizing the chances of success in smoking cessation. Previous studies have linked a higher dose of nicotine in nicotine replacement therapy to a higher success rate for smoking cessation. Thus, this study was performed to compare relief of urges to smoke, up until 5 h following treatment with a new 6 mg nicotine gum versus currently marketed 4 mg nicotine gum.
This was a randomized crossover clinical study. Following 12 h of abstinence from smoking, either one 6 mg or one 4 mg nicotine gum was given to 240 healthy adult smokers. Thereafter, urges to smoke were scored on a 100 mm Visual Analogue Scale repeatedly over 5 h.
The reductions in urges to smoke over the first 1 and 3 h after administration were statistically significantly greater with 6 mg than 4 mg gum, (p < 0.005). A 50% reduction in perceived urges to smoke was reached in 9.4 min with 6 mg gum compared to 16.2 min with 4 mg gum (median values). The median duration of a 50% or more reduction in VAS urges to smoke score was 111 min with the 6 mg gum, versus 74 min for the 4 mg gum.
This study provides evidence that the 6 mg nicotine gum provided a greater reduction, faster and longer relief of urges to smoke than the 4 mg nicotine gum.
EudraCT Number: 2010-023268-42. Study was first entered in EudraCT 2011-02-23.
能够控制吸烟欲望是提高戒烟成功率的关键。先前的研究表明,尼古丁替代疗法中的尼古丁剂量越高,戒烟成功率越高。因此,本研究旨在比较新的 6 毫克尼古丁口香糖与目前市场上的 4 毫克尼古丁口香糖在治疗后 5 小时内对吸烟欲望的缓解作用。
这是一项随机交叉临床试验。在 12 小时的戒烟期后,240 名健康成年吸烟者分别使用 1 片 6 毫克或 4 毫克尼古丁口香糖。此后,在 5 小时内,通过 100 毫米视觉模拟量表反复评估吸烟欲望。
与 4 毫克口香糖相比,6 毫克口香糖在给药后 1 小时和 3 小时内对吸烟欲望的抑制作用具有统计学意义(p<0.005)。使用 6 毫克口香糖,达到 50%吸烟欲望减少的时间为 9.4 分钟,而使用 4 毫克口香糖则为 16.2 分钟(中位数)。6 毫克口香糖使 VAS 吸烟欲望评分降低 50%或更多的中位数持续时间为 111 分钟,而 4 毫克口香糖则为 74 分钟。
本研究提供的证据表明,与 4 毫克尼古丁口香糖相比,6 毫克尼古丁口香糖能更快、更长时间地减轻吸烟欲望。
EudraCT 编号:2010-023268-42。该研究于 2011 年 2 月 23 日首次在 EudraCT 中注册。